The George Washington University Launches Online Master’s Degree and Graduate Certificate Programs in Regulatory Affairs

The George Washington University introduced its online graduate degree and certificate programs in regulatory affairs, which is now accepting applications for the fall 2014 term.

WASHINGTON (July 23, 2014) — The George Washington University (GW) is pleased to introduce its online graduate degree and certificate programs for regulatory affairs, which is now accepting applications for the fall 2014 term.

“The field of health care is in a state of rapid transformation,” says Daniela Drago, Ph.D., program director for regulatory affairs at the GW School of Medicine and Health Sciences. “With these changes, there is an increased demand for qualified regulatory professionals capable of leading change to improve development and delivery of safe, affordable and effective products, technology and medicine.”

GW’s online graduate program in regulatory affairs was developed in close collaboration with leading governmental regulatory agencies. Students will learn from current and former FDA officials, establishing close connections with international regulatory bodies located near and around GW’s Washington, D.C. campus.

Upon completion of the program, students will be able to lead and collaborate across business functions in the development and distribution of effective medical products or pharmaceuticals. The global perspective gained through the degree’s courses allows students to compete on an international level while building on their interaction with prominent officials and agencies, uniquely offered by GW’s program.

Professionals interested in furthering their career and opening the door to advancement within the growing field of regulatory affairs are invited to visit GW Online or call 1-844-386-7323 to speak with a program manager today and receive more information.

Latest News

Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…